ResearcherGunma UniversityActive in the last 2 years

Satoru Kakizaki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0224-7093; OpenAlex author ID A5090674063. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hidetoshi Yasuoka · 2 shared papers, 2022–2026 · strength 0.44
- Paper Clinical Utility of the Apolipoprotein A2 Isoform Index as a Tumor Marker for Pancreatic Cancer. DOI 10.1002/jgh3.70375 ↗
- Paper Efficacy and Safety of the Combination of Nano-Liposomal Irinotecan and 5-Fluorouracil/L-Leucovorin in Unresectable Adv… DOI 10.1159/000525742 ↗
Takashi Hoshino · 2 shared papers, 2022–2026 · strength 0.44
- Paper Clinical Utility of the Apolipoprotein A2 Isoform Index as a Tumor Marker for Pancreatic Cancer. DOI 10.1002/jgh3.70375 ↗
- Paper Efficacy and Safety of the Combination of Nano-Liposomal Irinotecan and 5-Fluorouracil/L-Leucovorin in Unresectable Adv… DOI 10.1159/000525742 ↗
Shomei Ryozawa · 1 shared paper, 2026 · strength 0.32
- Paper Clinical Utility of the Apolipoprotein A2 Isoform Index as a Tumor Marker for Pancreatic Cancer. DOI 10.1002/jgh3.70375 ↗
Norihiro Ishii · 1 shared paper, 2022 · strength 0.12
- Paper Efficacy and Safety of the Combination of Nano-Liposomal Irinotecan and 5-Fluorouracil/L-Leucovorin in Unresectable Adv… DOI 10.1159/000525742 ↗
Kenichiro Araki · 1 shared paper, 2022 · strength 0.12
- Paper Efficacy and Safety of the Combination of Nano-Liposomal Irinotecan and 5-Fluorouracil/L-Leucovorin in Unresectable Adv… DOI 10.1159/000525742 ↗
Ken Shirabe · 1 shared paper, 2022 · strength 0.12
- Paper Efficacy and Safety of the Combination of Nano-Liposomal Irinotecan and 5-Fluorouracil/L-Leucovorin in Unresectable Adv… DOI 10.1159/000525742 ↗
Hiroaki Hashizume · 1 shared paper, 2012 · strength 0.03
- Paper A case of hemorrhagic gastroduodenitis after proton beam radiation for pancreatic cancer with multiple hemorrhagic risk… DOI 10.1007/s12328-012-0329-y ↗
Masatomo Mori · 1 shared paper, 2012 · strength 0.03
- Paper A case of hemorrhagic gastroduodenitis after proton beam radiation for pancreatic cancer with multiple hemorrhagic risk… DOI 10.1007/s12328-012-0329-y ↗
Hideyuki Sakurai · 1 shared paper, 2012 · strength 0.03
- Paper A case of hemorrhagic gastroduodenitis after proton beam radiation for pancreatic cancer with multiple hemorrhagic risk… DOI 10.1007/s12328-012-0329-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.